Mylan CEO to testify in hearing on EpiPen price increases
WASHINGTON - The head of Mylan will face lawmakers' questions at a hearing next week on steep price hikes for the company's life-saving EpiPen injector device.
Mylan CEO Heather Bresch and officials from the Food and Drug Administration will testify before the House Oversight and Government Reform Committee.
The Republican chairman of the committee and the panel's top Democrat said in a statement that there is "justified outrage" from families and schools struggling to pay for the emergency allergy shots. The price has grown to $608 for a two-pack, up more than 500 percent since 2007.
Reps. Jason Chaffetz of Utah and Elijah Cummings of Maryland said they will also examine ways to encourage greater competition in the EpiPen market.
Bresch is the daughter of Democratic Sen. Joe Manchin of West Virginia.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Consumers prepare for Black Friday shopping differently this year
Christmas tree farms experience increase in business amid pandemic
Restaurants stay busy as families choose the to-go route for Thanksgiving meal
Family grateful for baby's miraculous recovery after mother died from Covid19
Firefighters demonstrate dangers of deep-frying a turkey for Thanksgiving feast
Belaire making 1st playoff appearance in 17 years Friday
Southeastern women blow out Alcorn State on opening day of college basketball...
Can Taysom Hill continue his success for the Saints?; Fantasy Focus with...
Catholic freshman Daniel Beale has been thrown into super stardom thanks to...
Can Jameis Winston lead this Saints offense?; Fantasy Focus Week 11 with...